97 related articles for article (PubMed ID: 1383355)
1. Effect of recombinant human granulocyte colony-stimulating factor (G-CSF) in the treatment of Pseudomonas aeruginosa bacteremia complicating hematologic malignancy--a preliminary study.
Funada H; Machi T; Ohtake S; Yoshida T; Matsuda T
Kansenshogaku Zasshi; 1992 Jan; 66(1):76-80. PubMed ID: 1383355
[TBL] [Abstract][Full Text] [Related]
2. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
[TBL] [Abstract][Full Text] [Related]
3. [Clinical approach to infection in patients with hematologic malignancy].
Funada H
Gan To Kagaku Ryoho; 1992 Feb; 19(2):178-83. PubMed ID: 1371045
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
Toyama K; Yaguchi M; Mizoguchi H; Masuda M; Urabe A; Ikeda Y; Aoki I; Shinbo T; Togawa A; Hirashima K; Miura Y; Hirose S; Tsuruoka N; Omine M; Kamakura M; Saito T; Arimori S; Aoki N; Kuraishi Y; Hirai H; Asano S; Mori M; Shirai T; Muto Y; Takaku F
Kansenshogaku Zasshi; 1996 Dec; 70(12):1242-53. PubMed ID: 9011117
[TBL] [Abstract][Full Text] [Related]
5. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of breakthrough bacteremia due to Pseudomonas aeruginosa with recombinant human granulocyte colony-stimulating factor in a patient with acute leukemia.
Funada H; Mizuhashi K; Machi T; Ohtake S; Matsuda T
Kansenshogaku Zasshi; 1991 May; 65(5):608-11. PubMed ID: 1715372
[No Abstract] [Full Text] [Related]
7. Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis.
Haberstroh J; Wiese K; Geist A; Dursunoglu GB; Gippner-Steppert C; Jochum M; von Specht BU
Shock; 1998 Feb; 9(2):128-34. PubMed ID: 9488258
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [III]. Prognostic factors].
Funada H; Machi T; Matsuda T
Kansenshogaku Zasshi; 1989 Aug; 63(8):880-5. PubMed ID: 2507688
[TBL] [Abstract][Full Text] [Related]
9. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
10. [Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice].
Tanaka N; Kumamoto Y; Hirose T; Yokoo A
Kansenshogaku Zasshi; 1990 Aug; 64(8):994-1003. PubMed ID: 1698897
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
12. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte colony-stimulating factor infusion and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report.
Chau WK; Lin CK; Chow MP; Wang SY; Liu JM; Ho CH; Chiu CF; Hsu HC; Tan TD; Chan WK
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):312-20. PubMed ID: 7530591
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Babalola CP; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
Gianni AM; Bregni M; Siena S; Magni M; Di Nicola M; Lombardi F; Tarella C; Pileri A; Bonadonna G
J Clin Oncol; 1992 Dec; 10(12):1955-62. PubMed ID: 1280674
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer.
Eguchi K; Shinkai T; Sasaki Y; Tamura T; Ohe Y; Nakagawa K; Fukuda M; Yamada K; Kojima A; Oshita F
Jpn J Cancer Res; 1990 Nov; 81(11):1168-74. PubMed ID: 1702415
[TBL] [Abstract][Full Text] [Related]
17. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [I]. Predisposing factors and clinical manifestations].
Funada H; Machi T; Matsuda T
Kansenshogaku Zasshi; 1989 Aug; 63(8):867-73. PubMed ID: 2507686
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
[TBL] [Abstract][Full Text] [Related]
19. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
[TBL] [Abstract][Full Text] [Related]
20. [Granulocyte colony-stimulating factor combination therapy of acute myeloid leukemia complicated with severe infection].
Miyabayashi M; Kitahara F; Ishii E; Koike K; Nakahata T; Komiyama A
Rinsho Ketsueki; 1994 Jan; 35(1):65-8. PubMed ID: 7511180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
